A critical discovery in cancer investigation is arising with the use of mini-antibodies to restore dysfunctional p53. This essential cancer inhibitor protein is frequently disabled in many types of tumors, resulting https://45listing.com/story24187785/vhh-fragments-reactivate-tumor-suppressor-p53-the-promising-hope-for-cancer-treatment